Peripheral insensate neuropathy-is height a risk factor?

G. S. Sharath Kote, Ajay N. Bhat, K. Thajuddeen, Mohammed H. Ismail, Abhishek Gupta

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Introduction: Peripheral insensate neuropathy is one of the most commonest and the earliest forms of peripheral neuropa-thy. It is one of the leading causes of the disability in working population who are at risk. Methods: A study was conducted in Kasturba medical college (Manipal university) in the year 2009-12, which included ex-amination of 818 people of more than 30yrs of age by random sampling method who were attending the outpatient clinic. A monofilament was used to determine the peripheral insensate neuropathy, which was defined by the presence of one or more insensate areas. Results: In our study, the prevalence of peripheral insensate neuropathy was 16. 2% (p-0. 0001), among which 9. 7% were males and 7. 5% were females. The males were 1. 27 times significantly at a higher risk than the females, even after a height adjustment to the gender difference in height. As the height increased, the prevalence of peripheral insensate neuropathy increased, irrespective of the diabetic and hypertensive statuses. The risk of the peripheral insensate neuropathy increases at a height of >167 cm in males and at a height of >159 cm in females. Conclusion: The authors conclude that body height is an im-portant and an independent risk factor for peripheral insensate neuropathy, irrespective of co morbidities. Height as a marker, helps the health care professionals in identifying the people who are at risk for peripheral insensate neuropathy.

Original languageEnglish
Pages (from-to)296-301
Number of pages6
JournalJournal of Clinical and Diagnostic Research
Volume7
Issue number2
DOIs
Publication statusPublished - 01-02-2013

Fingerprint

Peripheral Nervous System Diseases
Amination
Health care
Body Height
Ambulatory Care Facilities
Sampling
Cross-Sectional Studies
Morbidity
Delivery of Health Care

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

Sharath Kote, G. S., Bhat, A. N., Thajuddeen, K., Ismail, M. H., & Gupta, A. (2013). Peripheral insensate neuropathy-is height a risk factor? Journal of Clinical and Diagnostic Research, 7(2), 296-301. https://doi.org/10.7860/JCDR/2013/5140.2751
Sharath Kote, G. S. ; Bhat, Ajay N. ; Thajuddeen, K. ; Ismail, Mohammed H. ; Gupta, Abhishek. / Peripheral insensate neuropathy-is height a risk factor?. In: Journal of Clinical and Diagnostic Research. 2013 ; Vol. 7, No. 2. pp. 296-301.
@article{b11d9bab91ff45cc8b765b53b2b806ed,
title = "Peripheral insensate neuropathy-is height a risk factor?",
abstract = "Introduction: Peripheral insensate neuropathy is one of the most commonest and the earliest forms of peripheral neuropa-thy. It is one of the leading causes of the disability in working population who are at risk. Methods: A study was conducted in Kasturba medical college (Manipal university) in the year 2009-12, which included ex-amination of 818 people of more than 30yrs of age by random sampling method who were attending the outpatient clinic. A monofilament was used to determine the peripheral insensate neuropathy, which was defined by the presence of one or more insensate areas. Results: In our study, the prevalence of peripheral insensate neuropathy was 16. 2{\%} (p-0. 0001), among which 9. 7{\%} were males and 7. 5{\%} were females. The males were 1. 27 times significantly at a higher risk than the females, even after a height adjustment to the gender difference in height. As the height increased, the prevalence of peripheral insensate neuropathy increased, irrespective of the diabetic and hypertensive statuses. The risk of the peripheral insensate neuropathy increases at a height of >167 cm in males and at a height of >159 cm in females. Conclusion: The authors conclude that body height is an im-portant and an independent risk factor for peripheral insensate neuropathy, irrespective of co morbidities. Height as a marker, helps the health care professionals in identifying the people who are at risk for peripheral insensate neuropathy.",
author = "{Sharath Kote}, {G. S.} and Bhat, {Ajay N.} and K. Thajuddeen and Ismail, {Mohammed H.} and Abhishek Gupta",
year = "2013",
month = "2",
day = "1",
doi = "10.7860/JCDR/2013/5140.2751",
language = "English",
volume = "7",
pages = "296--301",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "2",

}

Sharath Kote, GS, Bhat, AN, Thajuddeen, K, Ismail, MH & Gupta, A 2013, 'Peripheral insensate neuropathy-is height a risk factor?', Journal of Clinical and Diagnostic Research, vol. 7, no. 2, pp. 296-301. https://doi.org/10.7860/JCDR/2013/5140.2751

Peripheral insensate neuropathy-is height a risk factor? / Sharath Kote, G. S.; Bhat, Ajay N.; Thajuddeen, K.; Ismail, Mohammed H.; Gupta, Abhishek.

In: Journal of Clinical and Diagnostic Research, Vol. 7, No. 2, 01.02.2013, p. 296-301.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Peripheral insensate neuropathy-is height a risk factor?

AU - Sharath Kote, G. S.

AU - Bhat, Ajay N.

AU - Thajuddeen, K.

AU - Ismail, Mohammed H.

AU - Gupta, Abhishek

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Introduction: Peripheral insensate neuropathy is one of the most commonest and the earliest forms of peripheral neuropa-thy. It is one of the leading causes of the disability in working population who are at risk. Methods: A study was conducted in Kasturba medical college (Manipal university) in the year 2009-12, which included ex-amination of 818 people of more than 30yrs of age by random sampling method who were attending the outpatient clinic. A monofilament was used to determine the peripheral insensate neuropathy, which was defined by the presence of one or more insensate areas. Results: In our study, the prevalence of peripheral insensate neuropathy was 16. 2% (p-0. 0001), among which 9. 7% were males and 7. 5% were females. The males were 1. 27 times significantly at a higher risk than the females, even after a height adjustment to the gender difference in height. As the height increased, the prevalence of peripheral insensate neuropathy increased, irrespective of the diabetic and hypertensive statuses. The risk of the peripheral insensate neuropathy increases at a height of >167 cm in males and at a height of >159 cm in females. Conclusion: The authors conclude that body height is an im-portant and an independent risk factor for peripheral insensate neuropathy, irrespective of co morbidities. Height as a marker, helps the health care professionals in identifying the people who are at risk for peripheral insensate neuropathy.

AB - Introduction: Peripheral insensate neuropathy is one of the most commonest and the earliest forms of peripheral neuropa-thy. It is one of the leading causes of the disability in working population who are at risk. Methods: A study was conducted in Kasturba medical college (Manipal university) in the year 2009-12, which included ex-amination of 818 people of more than 30yrs of age by random sampling method who were attending the outpatient clinic. A monofilament was used to determine the peripheral insensate neuropathy, which was defined by the presence of one or more insensate areas. Results: In our study, the prevalence of peripheral insensate neuropathy was 16. 2% (p-0. 0001), among which 9. 7% were males and 7. 5% were females. The males were 1. 27 times significantly at a higher risk than the females, even after a height adjustment to the gender difference in height. As the height increased, the prevalence of peripheral insensate neuropathy increased, irrespective of the diabetic and hypertensive statuses. The risk of the peripheral insensate neuropathy increases at a height of >167 cm in males and at a height of >159 cm in females. Conclusion: The authors conclude that body height is an im-portant and an independent risk factor for peripheral insensate neuropathy, irrespective of co morbidities. Height as a marker, helps the health care professionals in identifying the people who are at risk for peripheral insensate neuropathy.

UR - http://www.scopus.com/inward/record.url?scp=84873644800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873644800&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2013/5140.2751

DO - 10.7860/JCDR/2013/5140.2751

M3 - Article

VL - 7

SP - 296

EP - 301

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 2

ER -